AI Verdict
RRC has stronger fundamentals based on our AI analysis.
RRC vs RPRX Fundamental Comparison
| Metric | RRC | RPRX |
|---|---|---|
| Revenue | $3.1B | $2.4B |
| Net Income | $658.0M | $770.9M |
| Net Margin | 21.1% | 32.4% |
| ROE | 15.2% | 7.9% |
| ROA | 8.9% | 3.9% |
| Current Ratio | 0.67x | 2.40x |
| Debt/Equity | 0.28x | 0.92x |
| EPS | $2.74 | $1.78 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RRC vs RPRX: Frequently Asked Questions
Is RRC or RPRX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RRC has stronger fundamentals. RRC is rated BUY (70% confidence) while RPRX is rated HOLD (75% confidence). This is not investment advice.
How does RRC compare to RPRX fundamentally?
RANGE RESOURCES CORP has ROE of 15.2% vs Royalty Pharma plc's 7.9%. Net margins are 21.1% vs 32.4% respectively.
Which stock pays higher dividends, RRC or RPRX?
RRC has a dividend yield of N/A or no dividend while RPRX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RRC or RPRX for long term?
For long-term investing, consider that RRC has BUY rating with 70% confidence, while RPRX has HOLD rating with 75% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RRC vs RPRX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RRC vs RPRX, the AI consensus favors RRC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.